2m 2m 2m 2m 2m 2m 2m
SPERO THERAPETCS (SPRO)
NASDAQ
$2.18+$0.03 (+1.35%)
Price as of Jun 24, 2026 4:01 AM EDT- $128.0MMarket Cap
- -25.35%1-Year Change
- BiotechnologyIndustry
SPERO THERAPETCS (SPRO)
$2.18+$0.03 (+1.35%)
SPRO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.15 | ||
Change | -$0.06 (-2.71%) | ||
Open | $2.16 | ||
High | $2.23 | ||
Low | $2.15 | ||
Previous Close | $2.21 | ||
Volume | 609,657 | ||
30-Day Average Volume | 1,859,197 | ||
1-Week Change | -22.38% | ||
1-Month Change | -22.10% | ||
1-Year Change | -25.35% | ||
3-Year Change | 34.38% | ||
5-Year Change | -85.12% | ||
Fundamentals | |||
Shares Outstanding | 57.9M | ||
Total Assets | $59.0M | ||
Market Cap | $128.0M | ||
Enterprise Value | $71.9M | ||
Period: QTR TTM FY | |||
Revenue | $258,000.00 | ||
Net Income | -$7.2M | ||
Free Cash Flow | $15.9M | ||
EBIT | -$7.2M | ||
EBITDA | -$7.2M | ||
Net Working Capital | $52.1M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -10 | ||
Enterprise Value/Revenue | 279 | ||
P/B | 2 | ||
P/E | -17 | ||
PEG | 0 | ||
Price/Free Cash Flow | 8 | ||
Price/Operating Cash Flow | 8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue